Thus, filaggrin deficiency does not trigger inflammatory pathways specific to AD but might contribute to Th17 inflammation via regulation of T-cell priming in the thymus and to Langerhans cell activation via, inter alia, reduced levels of UCA, whose role in immunological reactions in the skin deserves further investigation [191]. The gene discussed is FLG; the disease is Alzheimer disease.